Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Sarepta will stop shipping Elevidys, Duchenne gene therapy
Health and Wellness

Sarepta will stop shipping Elevidys, Duchenne gene therapy

Last updated: July 21, 2025 8:45 pm
Share
Sarepta will stop shipping Elevidys, Duchenne gene therapy
SHARE

Sarepta Therapeutics made a surprising announcement on Monday evening, revealing that it will be pausing all shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy. This decision comes in response to a request from the Food and Drug Administration (FDA), which the company had initially rejected when it was issued on Friday.

According to Sarepta, shipments of Elevidys will come to a halt by the close of business on Tuesday evening. This move marks a significant shift for the company, as it had initially resisted the FDA’s request before ultimately complying with it.

The decision to pause shipments of Elevidys raises questions about the future of the gene therapy and its potential impact on patients with Duchenne muscular dystrophy. Sarepta had high hopes for Elevidys, which was developed to address the underlying genetic cause of the disease and potentially provide a much-needed treatment option for patients and their families.

In light of this development, stakeholders in the biotech and healthcare industries will be closely monitoring the situation to see how it unfolds. The pause in shipments raises concerns about the regulatory hurdles that Sarepta may be facing with Elevidys and the implications for the company’s overall drug development pipeline.

For more updates on this story and other developments in the biotech sector, subscribe to STAT+ for exclusive access to in-depth analysis and coverage. Stay tuned for further updates on Sarepta Therapeutics and the future of Elevidys as more information becomes available.

See also  Free OTC birth control, cholera deaths
TAGGED:DuchenneElevidysgeneSareptaShippingstopTherapy
Share This Article
Twitter Email Copy Link Print
Previous Article Dog’s Stepson Brought Child to Gun Range Years Before He Killed Teen
Next Article What’s Going on Between Tom Cruise and Ana de Armas? What’s Going on Between Tom Cruise and Ana de Armas?
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Cody Rhodes’ 39-year-old ally wears his jacket after WWE Saturday Night’s Main Event goes off the air

Cody Rhodes made a triumphant return to the wrestling ring in the main event of…

May 24, 2025

Trump Backs Uber-RINO Lindsey Graham in Shocking 2026 Endorsement |

Credit: The White House In a move that has raised eyebrows across the political spectrum,…

March 27, 2025

Republicans and NJ gov. candidate Jack Ciattarelli hammer Mikie Sherrill over asset gains while in Congress: ’She’s tripled her net worth’

Jack Ciattarelli, a candidate for governor in New Jersey, along with various Republican factions, has…

September 22, 2025

Cosmic Explorer, Laser Breakthroughs and the Next Generation of Gravitational-Wave Research

Gravitational waves have been a hot topic in the scientific community for the past few…

July 20, 2025

Astro Teller is joining the stage at Disrupt 2025 in October

Astro Teller, the head of Alphabet's X, the Moonshot Factory, is set to grace the…

April 24, 2025

You Might Also Like

Digital Twins Coming To Robotic Surgery
Health and Wellness

Digital Twins Coming To Robotic Surgery

October 31, 2025
Medicare, midterm elections, Vinay Prasad: Morning Rounds
Health and Wellness

Medicare, midterm elections, Vinay Prasad: Morning Rounds

October 31, 2025
Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests
Health and Wellness

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests

October 31, 2025
Once Again A Blood Pressure Medication Recall For Cancer Concerns
Health and Wellness

Once Again A Blood Pressure Medication Recall For Cancer Concerns

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?